Evidence map›Paper›PMID 20179045›Full record

ArticleProtein engineering, design & selection : PEDS2010

Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SQM variant.

Toni Hoffmann, Lukas Kurt Josef Stadler, Michael Busby, Qifeng Song, Anthony T Buxton, Simon D Wagner, Jason J Davis, Paul Ko Ferrigno

Open access · hybridAbstract read
In one paragraph

Article in Protein engineering, design & selection : PEDS, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Mechanisms Applied by Protein Inhibitors to Inhibit Cysteine Proteases.International journal of molecular sciences · 2021
    Review
  5. FimH as a scaffold for regulated molecular recognition.Journal of biological engineering · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Development of a multipurpose scaffold for the display of peptide loops.Protein engineering, design & selection : PEDS · 2017
    Article
  11. Non-antibody protein-based biosensors.Essays in biochemistry · 2016
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Toni HoffmannSection of Experimental Therapeutics, Leeds Institute of Molecular Medicine, St James's University Hospital, Beckett St, Leeds LS97TF, UK. t.hoffmann@leeds.ac.uk
Lukas Kurt Josef Stadler
Michael Busby
Qifeng Song
Anthony T Buxton
Simon D Wagner
Jason J Davis
Paul Ko Ferrigno
St James's University Hospital · GBMRC Cancer Unit · GBMRC Toxicology Unit · GBOxford Research Group · GBUniversity of Oxford · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F011296/1Medical Research Council MC_U105359876
6 · The paper itself

Abstract

Non-antibody scaffold proteins are used for a range of applications, especially the assessment of protein-protein interactions within human cells. The search for a versatile, robust and biologically neutral scaffold previously led us to design STM (stefin A triple mutant), a scaffold derived from the intracellular protease inhibitor stefin A. Here, we describe five new STM-based scaffold proteins that contain modifications designed to further improve the versatility of our scaffold. In a step-by-step approach, we introduced restriction sites in the STM open reading frame that generated new peptide insertion sites in loop 1, loop 2 and the N-terminus of the scaffold protein. A second restriction site in 'loop 2' allows substitution of the native loop 2 sequence with alternative oligopeptides. None of the amino acid changes interfered significantly with the folding of the STM variants as assessed by circular dichroism spectroscopy. Of the five scaffold variants tested, one (stefin A quadruple mutant, SQM) was chosen as a versatile, stable scaffold. The insertion of epitope tags at varying positions showed that inserts into loop 1, attempted here for the first time, were generally well tolerated. However, N-terminal insertions of epitope tags in SQM had a detrimental effect on protein expression.

Indexed as

Models, MolecularStructure-Activity RelationshipAmino Acid SubstitutionCircular DichroismCystatin AEscherichia coliImmunoprecipitationMicroarray AnalysisMutagenesisMutationProtein EngineeringProtein FoldingCystatin A

Identifiers

PMID20179045
PMCPMC2851446
OpenAlexW2113436244

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.